-
Law Firm investigating whether Anavex Life Sciences (AVXL) made
false and misleading statements to investors
-
Investors may have claims against the Company for securities fraud
-
To learn about the investigation, click here: http://www.cases-scott-scott.com/anavex/
Scott + Scott, LLP, a global investor rights law firm, has opened an
investigation to determine whether Anavex Life Sciences (AVXL) violated
the federal securities laws by issuing materially misleading information
to the investing public.
In particular, the firm is investigating whether Anavex issued
misleading statements and failed to disclose that the Company had used a
paid stock promoter to artificially inflate the Company’s share price.
On December 29, 2015, Anavex disclosed that it had received a subpoena
from the SEC on December 22, 2015. Anavex stated, in part, that “[t]he
Company believes the subpoena and investigation relate to the recent
unusual activity in the market for the Company’s shares.” Then on
December 30, 2015, Seeking Alpha published a report entitled
“Anavex: A Regulatory Target Damaged By Incriminating Evidence.” On this
news, Anavex stock fell $0.78, or 12.42%, to close at $5.50 per share.
To learn about the investigation, go to: http://www.cases-scott-scott.com/anavex/.
There is no cost or obligation to you.
You can also call the firm toll-free at 1-866-326-5057 or email scottlaw@scott-scott.com
for information about the investigation.
Scott + Scott, LLP has significant experience in prosecuting major
securities, antitrust, and employee retirement plan actions throughout
the United States. This release may be considered attorney advertising
in some jurisdictions under the applicable laws and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160222005862/en/
Copyright Business Wire 2016